• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘内白细胞介素-6水平与多发性硬化症的疾病进展及临床严重程度相关。

Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis.

作者信息

Itorralba Justine, Brand-Arzamendi Koroboshka, Saab Georges, Muccilli Alexandra, Schneider Raphael

机构信息

Department of Medicine, St. Michael's Hospital, Unity Health Toronto, 30 Bond St, 17th floor, Peter Gilgan Tower, Toronto, ON, M5B 1W8, Canada.

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

出版信息

BMC Neurol. 2025 Apr 2;25(1):136. doi: 10.1186/s12883-025-04145-0.

DOI:10.1186/s12883-025-04145-0
PMID:40175894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11963510/
Abstract

BACKGROUND

MS is characterized by persistent central nervous system (CNS) inflammation. Investigating the CNS-compartmentalized inflammation associated with progressive MS could uncover new biomarkers and therapeutic targets. Cerebrospinal fluid (CSF) interleukin-6 (IL-6) can be markedly elevated in neuroinflammatory conditions, such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. This study investigated the association between CSF IL-6 levels, progressive disease, and disease severity in MS.

METHODS

Advanced technologies, including single-molecule arrays and microfluidics, were used to analyse CSF samples from individuals with MS at the time of diagnosis for IL-6. IL-6 levels were then correlated with clinical course, disease severity, and other known biomarkers associated with inflammation and disease severity.

RESULTS

Elevated IL-6 levels in the CSF were found in individuals with progressive MS, and CSF IL-6 showed positive correlations with the Expanded Disability Status Scale, the Multiple Sclerosis Severity Score, and CSF glial fibrillary acidic protein levels.

CONCLUSIONS

IL-6 in CSF indicates ongoing CNS inflammation and may contribute to the compartmentalized inflammation associated with disease progression and overall disease severity.

摘要

背景

多发性硬化症(MS)的特征是中枢神经系统(CNS)持续存在炎症。研究与进展型MS相关的CNS分区炎症可能会发现新的生物标志物和治疗靶点。在神经炎性疾病,如视神经脊髓炎谱系障碍和髓鞘少突胶质细胞糖蛋白抗体相关疾病中,脑脊液(CSF)白细胞介素-6(IL-6)可显著升高。本研究调查了MS患者CSF中IL-6水平、疾病进展与疾病严重程度之间的关联。

方法

采用包括单分子阵列和微流控技术在内的先进技术,对MS患者诊断时的CSF样本进行IL-6分析。然后将IL-6水平与临床病程、疾病严重程度以及其他与炎症和疾病严重程度相关的已知生物标志物进行关联分析。

结果

进展型MS患者的CSF中IL-6水平升高,且CSF中IL-6与扩展残疾状态量表、多发性硬化症严重程度评分以及CSF胶质纤维酸性蛋白水平呈正相关。

结论

CSF中的IL-6表明CNS存在持续炎症,可能与疾病进展和整体疾病严重程度相关的分区炎症有关。

相似文献

1
Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis.鞘内白细胞介素-6水平与多发性硬化症的疾病进展及临床严重程度相关。
BMC Neurol. 2025 Apr 2;25(1):136. doi: 10.1186/s12883-025-04145-0.
2
Multifaceted Biomarkers Suggest a Similar Profile of CNS Pathology in Relapsing and Progressive MS.多方面生物标志物提示复发型和进展型多发性硬化症中枢神经系统病理学特征相似。
Eur J Neurol. 2025 Feb;32(2):e70052. doi: 10.1111/ene.70052.
3
Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities.血清游离轻链κ、可溶性白细胞介素-2 受体和白细胞介素-6 有助于探讨脑白质高信号患者。
Front Immunol. 2022 Mar 25;13:864133. doi: 10.3389/fimmu.2022.864133. eCollection 2022.
4
Cerebrospinal fluid interleukin-6 may be a biomarker for conversion of clinically isolated syndrome to neuromyelitis optica spectrum disorder.脑脊液白细胞介素-6可能是临床孤立综合征转化为视神经脊髓炎谱系障碍的生物标志物。
Mult Scler Relat Disord. 2025 Mar;95:106313. doi: 10.1016/j.msard.2025.106313. Epub 2025 Feb 2.
5
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.原发性进行性多发性硬化症中炎症和组织损伤的脑脊液生物标志物之间的关系。
Mult Scler Relat Disord. 2022 Dec;68:104209. doi: 10.1016/j.msard.2022.104209. Epub 2022 Oct 3.
6
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease.脑脊液白细胞介素-6 升高对髓鞘少突胶质细胞糖蛋白抗体相关疾病发病机制的影响。
Mult Scler. 2024 Jul;30(8):977-982. doi: 10.1177/13524585241254731. Epub 2024 May 23.
7
Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.多发性硬化症(MS)队列中的神经胶质和神经轴突生物标志物
Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:113-121.
8
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.在儿童单相脱髓鞘疾病和多发性硬化症中,白细胞介素-6升高与髓鞘少突胶质细胞糖蛋白抗体相关。
J Neuroimmunol. 2015 Dec 15;289:1-7. doi: 10.1016/j.jneuroim.2015.10.002. Epub 2015 Oct 8.
9
Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis.tau 磷酸化状态的生物标志物与多发性硬化症的临床病程相关。
Mult Scler Relat Disord. 2024 Oct;90:105801. doi: 10.1016/j.msard.2024.105801. Epub 2024 Aug 5.
10
Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.首发视神经脊髓炎谱系疾病中的细胞因子和组织损伤生物标志物:白细胞介素-6 的意义。
Neuroimmunomodulation. 2018;25(4):215-224. doi: 10.1159/000494976. Epub 2018 Dec 13.

引用本文的文献

1
Exploring the Link Between IL-6 rs1800795 G > C SNP and the Severity of Epstein-Barr Virus-Associated Multiple Sclerosis: Potential Impact on Cognitive Impairment.探索白细胞介素-6 rs1800795 G > C 单核苷酸多态性与爱泼斯坦-巴尔病毒相关多发性硬化症严重程度之间的联系:对认知障碍的潜在影响。
Mol Neurobiol. 2025 Jul 15. doi: 10.1007/s12035-025-05211-x.

本文引用的文献

1
Interleukin-6 Signaling Blockade Induces Regulatory Plasmablasts in Neuromyelitis Optica Spectrum Disorder.白细胞介素 6 信号阻断诱导视神经脊髓炎谱系障碍中的调节性浆细胞。
Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200266. doi: 10.1212/NXI.0000000000200266. Epub 2024 Jun 18.
2
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease.脑脊液白细胞介素-6 升高对髓鞘少突胶质细胞糖蛋白抗体相关疾病发病机制的影响。
Mult Scler. 2024 Jul;30(8):977-982. doi: 10.1177/13524585241254731. Epub 2024 May 23.
3
Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6.
危及生命的 MOG 抗体相关性出血性 ADEM 伴 CSF IL-6 升高。
Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200243. doi: 10.1212/NXI.0000000000200243. Epub 2024 Apr 17.
4
Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis.B细胞、小胶质细胞和巨噬细胞之间的相互作用及其对中枢神经系统局灶性炎症和进展性多发性硬化症的影响。
EBioMedicine. 2023 Oct;96:104789. doi: 10.1016/j.ebiom.2023.104789. Epub 2023 Sep 11.
5
GM-CSF is a marker of compartmentalised intrathecal inflammation in multiple sclerosis.GM-CSF 是多发性硬化症鞘内炎症分隔的标志物。
Mult Scler. 2023 Oct;29(11-12):1373-1382. doi: 10.1177/13524585231195861. Epub 2023 Sep 12.
6
Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study.脑脊液 GFAP 是预测首发帕金森病患者向痴呆和阿尔茨海默病相关生物标志物改变转化的生物标志物:一项前瞻性队列研究。
J Neuroinflammation. 2023 Jul 20;20(1):167. doi: 10.1186/s12974-023-02843-5.
7
Targeting IL-6 trans-signalling: past, present and future prospects.靶向 IL-6 转导信号:过去、现在和未来的前景。
Nat Rev Immunol. 2023 Oct;23(10):666-681. doi: 10.1038/s41577-023-00856-y. Epub 2023 Apr 17.
8
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.血清神经丝轻链与胶质纤维酸性蛋白作为多发性硬化症疾病进展的生物标志物比较。
JAMA Neurol. 2023 Mar 1;80(3):287-297. doi: 10.1001/jamaneurol.2022.5250.
9
Multiple sclerosis progression: time for a new mechanism-driven framework.多发性硬化症的进展:是时候建立一个新的基于机制的框架了。
Lancet Neurol. 2023 Jan;22(1):78-88. doi: 10.1016/S1474-4422(22)00289-7. Epub 2022 Nov 18.
10
Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis.血清 GFAP 和 NfL 水平可区分进展性多发性硬化症患者的后续进展和疾病活动。
Neurol Neuroimmunol Neuroinflamm. 2022 Nov 14;10(1). doi: 10.1212/NXI.0000000000200052. Print 2023 Jan.